Givaudan SA (OTCMKTS:GVDNY – Get Free Report) shares reached a new 52-week low on Thursday . The company traded as low as $74.6380 and last traded at $75.15, with a volume of 35820 shares traded. The stock had previously closed at $76.33.
Wall Street Analysts Forecast Growth
GVDNY has been the topic of several research reports. Jefferies Financial Group upgraded shares of Givaudan from a “hold” rating to a “buy” rating in a research note on Tuesday, November 11th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Givaudan in a report on Friday, January 30th. Citigroup restated a “neutral” rating on shares of Givaudan in a research report on Tuesday, February 3rd. Barclays raised shares of Givaudan from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 13th. Finally, The Goldman Sachs Group cut Givaudan from a “strong-buy” rating to a “sell” rating in a research note on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy”.
View Our Latest Analysis on Givaudan
Givaudan Stock Performance
Givaudan Company Profile
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Featured Stories
- Five stocks we like better than Givaudan
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
